Axa S.A. United Therapeutics Corp Transaction History

Axa S.A.

$33.6 Billion
Q2 2025

A detailed history of Axa S.A. transactions in United Therapeutics Corp stock. As of the latest transaction made, Axa S.A. holds 45,095 shares of UTHR stock, worth $19.1 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

45,095

Previous 42,082 7.16%

Holding current value

$19.1 Million

Previous $13 Million 0.11%

% of portfolio

0.04%

Previous 0.04%

37 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$276.47 - $328.4 $833,004 - $989,469	3,013 Added 7.16%	45,095 $13 Million
Q1 2025 May 15, 2025	SELL	$304.42 - $380.78 $1.74 Million - $2.18 Million	-5,730 Reduced 11.98%	42,082 $13 Million
Q4 2024 Feb 14, 2025	SELL	$348.66 - $410.0 $5.24 Million - $6.17 Million	-15,037 Reduced 23.93%	47,812 $16.9 Million
Q3 2024 Nov 14, 2024	SELL	$311.04 - $363.55 $681,488 - $796,538	-2,191 Reduced 3.37%	62,849 $22.5 Million
Q2 2024 Feb 25, 2025	BUY	$228.26 - $319.04 $3.93 Million - $5.5 Million	17,228 Added 36.03%	65,040 $20.7 Million
Q2 2024 Aug 14, 2024	BUY	$228.26 - $319.04 $1.87 Million - $2.62 Million	8,208 Added 14.44%	65,040 $20.7 Million
Q1 2024 May 15, 2024	BUY	$210.76 - $249.51 $729,440 - $863,554	3,461 Added 6.48%	56,832 $13.1 Million
Q4 2023 Jul 16, 2024	SELL	$214.88 - $256.94 $743,699 - $889,269	-3,461 Reduced 6.09%	53,371 $11.7 Million
Q4 2023 Feb 14, 2024	BUY	$214.88 - $256.94 $974,910 - $1.17 Million	4,537 Added 9.29%	53,371 $11.7 Million
Q3 2023 Nov 14, 2023	SELL	$211.82 - $248.24 $29,654 - $34,753	-140 Reduced 0.29%	48,834 $11 Million
Q2 2023 Aug 14, 2023	BUY	$205.19 - $232.99 $138,092 - $156,802	673 Added 1.39%	48,974 $10.8 Million
Q1 2023 May 15, 2023	SELL	$212.99 - $276.17 $257,504 - $333,889	-1,209 Reduced 2.44%	48,301 $10.8 Million
Q4 2022 Feb 14, 2023	BUY	$205.95 - $280.43 $172,586 - $235,000	838 Added 1.72%	49,510 $13.8 Million
Q3 2022 Feb 14, 2023	BUY	$203.3 - $244.17 $896,959 - $1.08 Million	4,412 Added 9.97%	48,672 $10.2 Million
Q3 2022 Nov 14, 2022	BUY	$203.3 - $244.17 $896,959 - $1.08 Million	4,412 Added 9.97%	48,672 $10.2 Million
Q2 2022 Feb 14, 2023	BUY	$174.81 - $241.14 $5.99 Million - $8.26 Million	34,260 Added 342.6%	44,260 $10.4 Million
Q2 2022 Aug 15, 2022	BUY	$174.81 - $241.14 $5.99 Million - $8.26 Million	34,260 Added 342.6%	44,260 $10.4 Million
Q1 2022 Feb 14, 2023	SELL	$166.16 - $213.96 $6.43 Million - $8.27 Million	-38,672 Reduced 79.45%	10,000 $1.79 Million
Q1 2022 May 13, 2022	SELL	$166.16 - $213.96 $5.37 Million - $6.91 Million	-32,293 Reduced 76.36%	10,000 $1.79 Million
Q4 2021 Feb 14, 2022	BUY	$184.32 - $216.08 $737,280 - $864,320	4,000 Added 10.45%	42,293 $9.14 Million
Q3 2021 Nov 15, 2021	BUY	$179.86 - $214.88 $3.2 Million - $3.82 Million	17,800 Added 86.86%	38,293 $7.07 Million
Q2 2021 Aug 13, 2021	SELL	$170.47 - $211.93 $7.18 Million - $8.92 Million	-42,100 Reduced 67.26%	20,493 $3.68 Million
Q1 2021 May 14, 2021	SELL	$153.94 - $174.85 $9.22 Million - $10.5 Million	-59,900 Reduced 48.9%	62,593 $10.5 Million
Q4 2020 Feb 12, 2021	SELL	$101.87 - $151.79 $3.24 Million - $4.83 Million	-31,800 Reduced 20.61%	122,493 $18.6 Million
Q3 2020 Nov 13, 2020	BUY	$99.9 - $121.13 $2.67 Million - $3.24 Million	26,719 Added 20.94%	154,293 $15.6 Million
Q2 2020 Aug 14, 2020	BUY	$92.74 - $125.82 $4.1 Million - $5.56 Million	44,167 Added 52.95%	127,574 $15.4 Million
Q1 2020 May 15, 2020	SELL	$79.39 - $115.35 $848,917 - $1.23 Million	-10,693 Reduced 11.36%	83,407 $7.91 Million
Q4 2019 Feb 18, 2020	BUY	$78.31 - $95.34 $6.46 Million - $7.87 Million	82,500 Added 711.21%	94,100 $8.29 Million
Q3 2019 Nov 14, 2019	SELL	$74.85 - $85.99 $2.91 Million - $3.35 Million	-38,900 Reduced 77.03%	11,600 $925,000
Q2 2019 Aug 13, 2019	SELL	$76.06 - $120.81 $1.32 Million - $2.09 Million	-17,300 Reduced 25.52%	50,500 $3.94 Million
Q1 2019 May 14, 2019	BUY	$107.15 - $126.84 $1.15 Million - $1.36 Million	10,712 Added 18.76%	67,800 $7.96 Million
Q4 2018 Feb 13, 2019	BUY	$101.4 - $128.73 $1.07 Million - $1.36 Million	10,600 Added 22.8%	57,088 $6.22 Million
Q3 2018 Nov 08, 2018	SELL	$113.81 - $129.46 $534,907 - $608,462	-4,700 Reduced 9.18%	46,488 $5.95 Million
Q2 2018 Aug 13, 2018	SELL	$101.14 - $118.31 $13,451 - $15,735	-133 Reduced 0.26%	51,188 $5.79 Million
Q1 2018 May 14, 2018	SELL	$107.21 - $151.94 $2.04 Million - $2.89 Million	-19,000 Reduced 27.02%	51,321 $5.77 Million
Q4 2017 Feb 13, 2018	BUY	$118.58 - $151.28 $437,797 - $558,525	3,692 Added 5.54%	70,321 $10.4 Million
Q3 2017 Nov 13, 2017	BUY	$114.6 - $136.81 $7.64 Million - $9.12 Million	66,629	66,629 $7.81 Million

Others Institutions Holding UTHR

# of Institutions

750

Shares Held

43.4M

Call Options Held

340K

Put Options Held

318K

View Full List

About UNITED THERAPEUTICS Corp

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $19.2B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

More about UTHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Axa S.A., based on Form 13F filings with the SEC.

News

Stay updated on Axa S.A. with notifications on news.

Account